Individuals with the APOE-ε4 allele had a greater likelihood of having microbleeds than expected for age, suggesting that even in the context of amyloid precursor protein overproduction due to triplication of the 21st chromosome in Down syndrome, APOE-ε4 can still affect disease progression42. This evidence concerns the gene APP and Down syndrome.